What would you do if you were faced with one of these 18 challenging cases? The experts provide advice on handling device misadventures, subluxated IOLs, aqueous misdirection, wound burn, suprachoroidal hemorrhage, and more.
The March CME supplement from MedEdicus can be found here: Understanding Meibomian Gland Dysfunction as a Driver for Dry Eye Disease.
Explore TEPEZZA® (teprotumumab-trbw) now
for your patients with this serious, progressive disease.
TEPEZZA is a trademark owned by or licensed to Horizon.
© 2022 Horizon Therapeutics plc P-TEP-US-00805 12/22